Interferon gamma for the treatment of asthma

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) A61K 31/573 (2006.01) A61P 11/06 (2006.01)

Patent

CA 2387089

The invention describes for the first time the successful clinical application of interferon gamma (IFN-.gamma.) in human bronchial asthma therapy. The clinical data show unambiguously that continuous application of IFN-.gamma. in relatively low doses can be successfully used for long-term treatment of severe asthma bronchiale, especially for glucocorticoid-resistant asthma. The invention relates also to a combination therapy administering IFN-.gamma. and glucocorticoids, which alone are not or not sufficiently effective in asthma therapy.

L'invention concerne l'application clinique réussie et inédite de l'interféron gamma (IFN-.gamma.) dans la thérapie de l'asthme bronchique humain. Les données cliniques montrent sans ambiguïté que l'application continue d'IFN-.gamma. à doses relativement faibles permet de traiter à long terme l'asthme bronchique grave avec succès, spécialement l'asthme résistant aux glucocorticoïdes. L'invention concerne également une thérapie combinant IFN-.gamma. et glucocorticoïdes, qui, administrés seuls, ne sont pas ou pas assez efficaces dans la thérapie de l'asthme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Interferon gamma for the treatment of asthma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interferon gamma for the treatment of asthma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon gamma for the treatment of asthma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1892732

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.